Blog

​Johnson & Johnson makes $15 billion bet on mental-health drugs 

13 de janeiro de 2025 by in News

​Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through 2029.